NIH RADx Tech Portfolio of Technologies

October 20, 2020

NIH RADx Tech Portfolio of Technologies

Please join us for the second installment in an informative three-part webinar series that will present NIH’s RADx Tech Program and how it is being leveraged to accelerate the innovation pipeline of technology and deploy them to meet today's most pressing health needs in resolving the COVID-19 pandemic.

The current diagnosis of acute SARS-CoV-2 infection relies on tests that detect either viral RNA or viral antigens. We will explore the currently marketed gold standard COVID-19 tests. We also will review the different types of novel sample and detection technologies being developed and funded by RADx program that have the potential of revolutionizing testing for SARS-CoV-2 in the USA. The session will offer an assessment on how these technologies can help improve the COVID-19 testing capacity in the US.

Speaker: Dr. Daniel Marshak, PhD, CIMIT Consultant

The Consortia for Improving Medicine with Innovation & Technology (CIMIT) is a network of world-class academic and medical institutions partnering with industry and government. Its mission is to foster collaboration among clinicians, technologists, and entrepreneurs to accelerate innovation and catalyze the discovery, development, and implementation of innovative healthcare technologies.